Journal article Published 2020
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma
Future Oncology 17(3), 241-254 (2020)
- 2020 Year
- 33016119 PMID
Cite this publication
SPISAROVÁ, M., B. MELICHAR, D. VITÁSKOVÁ, H. ŠTUDENTOVÁ: Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma. Future Oncology. 2020, 17(3), 241-254, ISSN: 1479-6694, PMID: 33016119.
Details
- ISSN
- 1479-6694